CVRx (CVRX) EBT Growth (1y) (2021 - 2026)
CVRx (CVRX) EBT Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | -29.12% |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 53.94% |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 45.44% |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 12.65% |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 29.89% |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 31.69% |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 13.05% |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 71.38% |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 17.94% |
| 10 | CVRx | 75.83 Mn | 11.25 Mn | 13.72 Mn | 4.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.74% |
| Mar 31, 2026 | 4.73% |
| Dec 31, 2025 | -11.24% |
| Sep 30, 2025 | 1.37% |
| Jun 30, 2025 | -5.37% |
| Mar 31, 2025 | 37.82% |
| Dec 31, 2024 | -17.65% |
| Sep 30, 2024 | -45.49% |
| Jun 30, 2024 | -20.41% |
| Mar 31, 2024 | -95.31% |
| Dec 31, 2023 | 13.17% |
| Sep 30, 2023 | 8.44% |
| Jun 30, 2023 | -5.15% |
| Mar 31, 2023 | -13.80% |
| Dec 31, 2022 | 0.35% |
| Sep 30, 2022 | -60.36% |
| Jun 30, 2022 | 37.66% |
| Mar 31, 2022 | -15.74% |
| Dec 31, 2021 | -211.89% |
| Sep 30, 2021 | -90.46% |